Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: retrospective study of computerised general practice records.

PubWeight™: 3.15‹?› | Rank: Top 1%

🔗 View Article (PMC 28684)

Published in BMJ on October 10, 1998

Authors

B D Pethica1, A Penrose, D MacKenzie, J Hall, R Beasley, M Tilyard

Author Affiliations

1: Wellington Asthma Research Group, Wellington School of Medicine, University of Otago, Wellington, PO Box 7343, Wellington South, New Zealand. WARG.Sec@wnmeds.ac.nz

Articles cited by this

A case-control study of deaths from asthma. Thorax (1986) 3.97

The computer research network of the Royal New Zealand College of General Practitioners: an approach to general practice research in New Zealand. Br J Gen Pract (1996) 2.32

Risk factors for death in patients admitted to hospital with asthma: a follow-up study. Aust N Z J Med (1991) 2.07

Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol (1992) 1.92

Biases in estimates from the RNZCGP computer research group. N Z Med J (1995) 1.86

A comparison of beclomethasone dipropionate and budesonide in the treatment of asthma. Br J Clin Pract (1993) 1.67

Urine cortisol excretion in children treated with high doses of inhaled corticosteroids: a comparison of budesonide and beclomethasone. Eur Respir J (1988) 1.32

Clinical pharmacology of corticosteroids in bronchial asthma. Pharmacol Ther (1993) 1.20

Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate. Arch Dis Child (1995) 1.10

Dose-response of inhaled drugs in asthma. An update. Clin Pharmacokinet (1997) 1.06

Budesonide inhaled via Turbuhaler: a more effective treatment for asthma than beclomethasone dipropionate via Rotahaler. Ann Allergy Asthma Immunol (1995) 1.02

High-dose inhaled steroids in the management of asthma. A comparison of the effects of budesonide and beclomethasone dipropionate on pulmonary function, symptoms, bronchial responsiveness and the adrenal function. Allergy (1992) 0.97

How should inhaled glucocorticoids be compared? J Allergy Clin Immunol (1997) 0.97

Articles by these authors

(truncated to the top 100)

International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J (1995) 13.01

Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis (1981) 7.00

Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ (1993) 6.14

Genome sequence of Halobacterium species NRC-1. Proc Natl Acad Sci U S A (2000) 5.87

Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet (1989) 5.82

End of the New Zealand asthma mortality epidemic. Lancet (1995) 4.88

Effects of organizational change in the medical intensive care unit of a teaching hospital: a comparison of 'open' and 'closed' formats. JAMA (1996) 4.71

A mesoscale phytoplankton bloom in the polar Southern Ocean stimulated by iron fertilization. Nature (2000) 4.36

Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89

Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87

Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nat Med (1998) 3.75

Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax (2009) 3.72

Subepithelial fibrosis in the bronchi of asthmatics. Lancet (1989) 3.70

Hippocampal volume in adolescent-onset alcohol use disorders. Am J Psychiatry (2000) 3.67

Rapid active transport of immunoglobulin A from blood to bile. J Exp Med (1978) 3.62

Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax (1991) 3.39

Beta agonists and asthma mortality: déjà vu. Clin Exp Allergy (1991) 3.39

Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study. Lancet (2003) 3.34

Worldwide worsening wheezing--is the cure the cause? Lancet (1992) 3.30

Monoclonal antibodies to rhodopsin: characterization, cross-reactivity, and application as structural probes. Biochemistry (1983) 3.30

Cannabis use and risk of lung cancer: a case-control study. Eur Respir J (2008) 3.29

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med (1992) 3.23

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy (2005) 3.22

Sex differences in brain maturation during childhood and adolescence. Cereb Cortex (2001) 3.17

How much asthma is really attributable to atopy? Thorax (1999) 3.04

Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax (1990) 3.02

COPD prevalence in a random population survey: a matter of definition. Eur Respir J (2007) 2.97

A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet (1999) 2.88

Large scale identification of genes involved in cell surface biosynthesis and architecture in Saccharomyces cerevisiae. Genetics (1997) 2.81

The nucleotide sequence of chromosome I from Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1995) 2.74

Practical management of hyperinsulinism in infancy. Arch Dis Child Fetal Neonatal Ed (2000) 2.70

The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods. Int J Tuberc Lung Dis (2005) 2.65

The self-administration of inhaled beta agonist drugs during severe asthma. N Z Med J (1990) 2.61

Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure. Chest (1990) 2.61

Evaluation of anticoagulant control in a pharmacist operated anticoagulant clinic. J Clin Pathol (1995) 2.58

Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J Virol (1993) 2.58

Occurrence of specific antibodies of the IgA class in the bile of rats. Int Arch Allergy Appl Immunol (1979) 2.46

Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect (2003) 2.40

Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J (2009) 2.37

Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax (2010) 2.36

Pre-hospital oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Intern Med J (2010) 2.27

Localization of binding sites for carboxyl terminal specific anti-rhodopsin monoclonal antibodies using synthetic peptides. Biochemistry (1984) 2.22

Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. J Immunol Methods (1982) 2.16

Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15

The impact of course attendance on the practice of dentists. Br Dent J (2004) 2.08

Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? Gene Ther (2006) 2.07

Beta-agonist therapy and asthma mortality in Japan. Lancet (1998) 2.06

Septicemia caused by Pseudomonas paucimobilis. Am J Clin Pathol (1979) 2.06

Baseline risk for asthma deaths. N Z Med J (1992) 2.02

The management of oesophageal carcinoma: radiotherapy or surgery? Cost considerations. Eur J Cancer Clin Oncol (1989) 2.00

Quality of life measured by the St George's Respiratory Questionnaire and spirometry. Eur Respir J (2009) 1.99

The recognition and management of melanoma and other skin lesions by general practitioners in New Zealand. N Z Med J (1994) 1.99

Perinatal factors and atopic disease in childhood. Clin Exp Allergy (1997) 1.96

Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax (2005) 1.95

Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology (1997) 1.94

Spatial separation of protein domains is not necessary for catalytic activity or substrate binding in a xylanase. Biochem J (1990) 1.93

Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol (1992) 1.92

Eugenics in Britain. Soc Stud Sci (1976) 1.88

Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax (1989) 1.87

The effects of early and late paracetamol exposure on asthma and atopy: a birth cohort. Clin Exp Allergy (2010) 1.79

Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart (2008) 1.78

The N-terminal region of an endoglucanase from Pseudomonas fluorescens subspecies cellulosa constitutes a cellulose-binding domain that is distinct from the catalytic centre. Mol Microbiol (1990) 1.76

Biological functions of p53 isoforms through evolution: lessons from animal and cellular models. Cell Death Differ (2011) 1.74

Molecular identification of microorganisms from endodontic infections. J Clin Microbiol (2001) 1.73

The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three. Clin Exp Allergy (2013) 1.72

Predisposition to and late onset of upper airway obstruction following angiotensin-converting enzyme inhibitor therapy. Chest (1992) 1.70

Biogeography and ecological setting of Indian Ocean hydrothermal vents. Science (2001) 1.69

Paracetamol in pregnancy and the risk of wheezing in offspring: a systematic review and meta-analysis. Clin Exp Allergy (2011) 1.68

The effects of a neuregulin 1 variant on white matter density and integrity. Mol Psychiatry (2007) 1.68

Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ (2001) 1.67

Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med (1996) 1.66

Spontaneous remission of primary hyperparathyroidism from parathyroid apoplexy. J Clin Endocrinol Metab (1996) 1.66

Evidence for a general role for non-catalytic thermostabilizing domains in xylanases from thermophilic bacteria. Biochem J (1995) 1.64

International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax (2000) 1.64

Pseudoaneurysm of the inferior gluteal artery. Can Assoc Radiol J (1992) 1.63

Elevated protease activities in human amnion and chorion correlate with preterm premature rupture of membranes. Am J Obstet Gynecol (1995) 1.62

Systematic review of the dose-response relation of inhaled fluticasone propionate. Arch Dis Child (2004) 1.62

Right amygdala volume in adolescent and young adult offspring from families at high risk for developing alcoholism. Biol Psychiatry (2001) 1.57

Dark matter search results from the CDMS II experiment. Science (2010) 1.57

Using graded motor imagery for complex regional pain syndrome in clinical practice: failure to improve pain. Eur J Pain (2011) 1.56

Hydrocephalus in achondroplasia: the possible role of intracranial venous hypertension. J Neurosurg (1989) 1.55

Self efficacy as a mediator of the relationship between pain intensity, disability and depression in chronic pain patients. Pain (1999) 1.54

Molecular cloning of multiple xylanase genes from Pseudomonas fluorescens subsp. cellulosa. J Gen Microbiol (1988) 1.53

Incremental change in the Australian health care system. Health Aff (Millwood) (1999) 1.52

Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis bacillus Calmette-Guérin in adult asthma. Clin Exp Allergy (2004) 1.51

Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics. Respir Med (1992) 1.51

Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis. Eur Respir J (2004) 1.50

Case-control study of salmeterol and near-fatal attacks of asthma. Thorax (1998) 1.49

Is allergen exposure the major primary cause of asthma? Thorax (2000) 1.48

The blockade of Fc receptor-mediated clearance of immune complexes in vivo by a monoclonal antibody (2.4G2) directed against Fc receptors on murine leukocytes. J Immunol (1984) 1.48

The effect of the increased prescription charges on the collection of asthma drugs. N Z Med J (1992) 1.48

A study of the management of asthma in a hospital emergency department. N Z Med J (1989) 1.47

A pilot longitudinal study of hippocampal volumes in pediatric maltreatment-related posttraumatic stress disorder. Biol Psychiatry (2001) 1.46

Call for worldwide withdrawal of benzalkonium chloride from nebulizer solutions. J Allergy Clin Immunol (2001) 1.46

Lumbar spine surgery in the obese patient. J Spinal Disord (1997) 1.45

Accuracy of a portable interpretive ECG machine in diagnosis of acute evolving myocardial infarction. Aust N Z J Med (1992) 1.44

Antibiotic use in early childhood and the development of asthma. Clin Exp Allergy (1999) 1.43

Mutations in the follicle-stimulating hormone receptor and familial dizygotic twinning. Lancet (2001) 1.43

Utilisation as a measure of equity: weighing heat? J Health Econ (1991) 1.43

A general-practitioner survey of the Abortion Act 1967. Practitioner (1971) 1.42